Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Topics : Vascular diseases
  • Active substance : nimodipine
  • Active substance : sodium
  • Active substance : urapidil
Filter
Topic
  • Economics and public health (1)
  • Plus ...
    • Organisation of care (1)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Emergency treatment and intensive care (1)
  • Diseases and conditions (1)
  • Plus ...
    • Nervous system diseases (1)
    • Plus ...
      • Central nervous system diseases (1)
    • Vascular diseases (1)
    • Plus ...
      • Cerebrovascular disorders (1)
Content type
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Practice guidelines (1)
Language
  • Français (1)
Active substance
  • aminophylline (1)
  • aspirine (1)
  • chlorure de sodium (1)
  • dextran (1)
  • dextran 40 (1)
  • dipyridamole (1)
  • glycine (1)
  • iode (1)
  • mannitol (1)
  • nimodipine (1)
  • pentifylline (1)
  • potassium (1)
  • sodium (1)
  • streptokinase (1)
  • urapidil (1)

Practice guidelines and other guides - 1 result

  • Early management of adult stroke patients - Medical aspects -

    Practice guidelines - Posted on 1/9/2002
    Download abstract
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
zvf4mF7vK8vS0vzJ